drugset / Trial / NCT00012246
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
Phase 2
Terminated
7 enrolled
The University of Texas Medical Branch, Galveston
National Cancer Institute (NCI) · collab
RandomizedTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two different vaccines in treating patients who have cancer of the gastrointestinal tract.
Timeline
- Start
- 2002-07
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carcinoembryonic antigen peptide 1-6D | Unknown | — | Subcutaneous |
| Subject | incomplete Freund's adjuvant | Other / unclassified | — | Subcutaneous |
| Subject | sargramostim | Protein / enzyme biologic | — | Other |